Myriad Genetics, Inc. (MYGN)
NASDAQ: MYGN · Real-Time Price · USD
5.12
+0.31 (6.44%)
At close: Mar 10, 2026, 4:00 PM EDT
5.25
+0.13 (2.54%)
After-hours: Mar 10, 2026, 7:45 PM EDT

Myriad Genetics Ratios and Metrics

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Mar '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
4795751,2521,7211,1782,208
Market Cap Growth
-62.91%-54.06%-27.25%46.04%-46.64%48.12%
Enterprise Value
538.96628.331,2771,7161,1941,949
Last Close Price
5.126.1513.7119.1414.5127.60
PE Ratio
--1.56-9.72-6.02-10.44-78.86
Forward PE
86.78196.49141.34---
PS Ratio
0.580.701.492.281.743.20
PB Ratio
1.301.561.792.201.332.28
P/TBV Ratio
1.291.551.772.021.322.22
P/FCF Ratio
--41.67-45.19-9.88-7.773680.00
P/OCF Ratio
265.98319.46-143.88-15.52-11.08118.71
EV/Sales Ratio
0.650.761.522.281.762.82
EV/EBITDA Ratio
--1.88-20.49-8.78-13.59-15.26
EV/EBIT Ratio
--1.62-10.34-6.67-8.49-10.23
EV/FCF Ratio
--45.53-46.09-9.85-7.883247.50
Debt / Equity Ratio
0.550.550.180.170.150.08
Debt / EBITDA Ratio
-0.63-0.63-2.25-0.78-1.65-0.72
Debt / FCF Ratio
-15.20-15.20-5.07-0.87-0.96153.83
Net Debt / Equity Ratio
0.160.160.050.010.03-0.25
Net Debt / EBITDA Ratio
-0.18-0.18-0.61-0.06-0.341.93
Net Debt / FCF Ratio
-4.36-4.36-1.37-0.06-0.20-410.83
Asset Turnover
0.950.950.770.640.540.50
Inventory Turnover
8.538.5310.1911.2211.419.32
Quick Ratio
1.981.981.361.641.582.11
Current Ratio
2.492.491.822.012.002.37
Return on Equity (ROE)
-68.45%-68.45%-17.15%-31.55%-12.08%-2.94%
Return on Assets (ROA)
-41.35%-41.35%-11.71%-22.04%-8.89%-6.63%
Return on Invested Capital (ROIC)
-59.57%-59.57%-15.53%-28.30%-12.79%-9.26%
Return on Capital Employed (ROCE)
-53.92%-53.92%-13.32%-25.09%-12.91%-15.95%
Earnings Yield
-76.43%-64.23%-10.28%-16.61%-9.58%-1.27%
FCF Yield
-2.88%-2.40%-2.21%-10.12%-12.87%0.03%
Buyback Yield / Dilution
0.70%0.70%0.60%-6.67%0.36%-3.64%
Updated Dec 31, 2025. Data Source: Fiscal.ai. Standard template. Financial Sources.
SEC Filings: 10-K · 10-Q